In MASLD, How Can Spatial Genomics Improve Understanding of the Disease?

Sobia Laique

Spatial genomics is this new revolutionary technology that really maps the location of genes and their activity within a specific tissue. So unlike traditional genomics, which provide a bulk analysis of a tissue, in spatial genomics, what you're really getting is a detailed, high-resolution view of cellular heterogeneity and the spatial organization, which really allows researchers to understand how different cell types in liver tissue are interacting, how gene expression will vary depending on the tissue, and how these factors will contribute to disease development and then progression. So if we look at spatial genomics within MASLD and really the application of it, this is relatively new and we're seeing it grow pretty rapidly. And what this technology has really allowed us to get a better understanding of is, number one, mapping cellular heterogeneity. And why that's important is because one has to realize that there's a very complex interplay of various cell types. Everything from your hepatocytes, to stellate cells, to immune cells that are really interacting in the disease progression of MASLD. And then the second thing we've learned is it's allowed us to reveal spatial patterns of gene expression. So how do certain genes behave in expression or in response to certain environmental triggers, which are dictated by a patient's obesity, degree of insulin resistance, or say, even their gut microbiome. Thirdly, it allows us to identify disease microenvironments. And that's very, very important because it's these specific microenvironments that we really have to study to understand where can we develop therapeutic targets to halt fibrosis and then allow for fibrosis regression. And so, in summary, I would say I think it's allowed us to develop or gain unprecedented insights into the complex cellular and molecular pathogenesis of MASLD, but there's still a long way to go to see how this advances our understanding of the disease down the line.